secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2021-11-02T23:59:59+00:00
Accession:  0001638833-21-000144
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q3 revenue up 12.7% to $559.2M; raises FY EBITDA guidance to $325-330M
--------------------------------------------------------------------------------

- Revenue $559.2M (+12.7% YoY); net loss $22.9M; adjusted EBITDA $76.4M (+25% YoY).
- Same-facility revenue +8.3%, case volume +6.2% vs prior year quarter.
- FY 2021 adjusted EBITDA guidance raised to $325M-$330M.
- Deployed over $130M on acquisitions YTD; 3 ASCs bought in Aug; $225M under LOI.
- Cash $330.4M; revolver capacity $163M; net debt/EBITDA ratio 6.25x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883321000144/0001638833-21-000144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883321000144/sgry-20211102.htm
  HTML page:      https://secwatch.observer/filing/0001638833-21-000144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer